3. 脊髄性筋萎縮症 Spinal muscular atrophy Clinical trials / Disease details


臨床試験数 : 237 薬物数 : 123 - (DrugBank : 29) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 75

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02855112
(ClinicalTrials.gov)
June 201522/7/2016Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman PatientsThe Effectiveness of Allogeneic Adipose Derived Mesenchymal Stem Cells (ADMSCs) in the Phenotypic Changes of Werdnig Hoffman PatientsInfantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]Biological: Adipose derived mesenchymal stem cellTehran University of Medical SciencesNULLRecruiting5 Months12 MonthsBoth10Phase 1/Phase 2Iran, Islamic Republic of